About VISUfarma - the eye health company

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
pharmaceuticals
Location
Location
Amstelplein 1,Amsterdam,North Holland,NL
Description
Information
VISUfarma is a company with a clear perspective: to bring global innovation to European eye health. It is an ambitious and fast growing pan-European player, commercializing a wide portfolio of ophthalmic products and devices. VISUfarma lives up to its promise to offer high-quality products and to spread eye health innovation and knowledge, from across the globe, throughout Europe. This is powered by the acquisition of the international commercial operations of Nicox SA (France) and Visufarma SpA (Italy) and will be further developed by partnering with US licensing partners. VISUfarma manages a unique network in the ophthalmology world which enables doctors, hospitals and clinics to provide patients with the best eye care.VISUfarma was founded in 2016 and is currently active in 5 European countries: France, Germany, Italy, Spain and the United Kingdom. The company has more than 175 employees and its head office is based in Amsterdam, the Netherlands.

VISUfarma - the eye health company Alternatives

Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
Pharmaceuticals

Frequently Asked Questions about VISUfarma - the eye health company

What is VISUfarma - the eye health company email format?

The widely used VISUfarma - the eye health company email format is {f}.{last} (e.g. [email protected]) with 75% adoption across the company.


What is VISUfarma - the eye health company customer service number?

To contact VISUfarma - the eye health company customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more